Point/Counterpoint: The role of reirradiation in recurrent glioblastoma
Neuro Oncol
.
2024 Nov 11:noae209.
doi: 10.1093/neuonc/noae209.
Online ahead of print.
Authors
Rifaquat Rahman
1
,
Matthias Preusser
2
,
Christina Tsien
3
,
Emilie Le Rhun
4
,
Erik P Sulman
5
6
,
Patrick Y Wen
7
,
Giuseppe Minniti
8
9
,
Michael Weller
10
Affiliations
1
Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
2
Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
3
Department of Oncology (Radiation Oncology), McGill University, Montreal, Quebec, Canada.
4
Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
5
Department of Radiation Oncology, New York University Grossman School of Medicine, New York, New York, USA.
6
Department of Neurosurgery, New York University Grossman School of Medicine, New York, New York, USA.
7
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
8
IRCCS Neuromed, Pozzilli (IS), Italy.
9
Department of Radiological Sciences, Oncology, and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.
10
Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
PMID:
39527460
DOI:
10.1093/neuonc/noae209
No abstract available